These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6728086)

  • 1. Renal handling of uric acid in patients with recurrent calcium nephrolithiasis and hyperuricosuria.
    Mateos Antón F; Puig JG; Gaspar G; Muñoz Sanz A; Herrero E; Ramos T; Martínez ME; Gómez Mantilla JM
    Nephron; 1984; 37(2):123-7. PubMed ID: 6728086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of uric acid transport in nephrons of patients with calcium nephrolithiasis and hyperuricosuria].
    Tykarski A; Pupek-Musialik D; Posadzy-Małaczyńska A
    Pol Arch Med Wewn; 1993 Jul; 90(1):26-33. PubMed ID: 8234002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of urate in patients with calcium stone disease.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    Nephron; 1982; 31(1):31-6. PubMed ID: 7110473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypouricemia due to renal tubular defect. A study with the probenecid-pyrazinamide test.
    Smetana SS; Bar-Khayim Y
    Arch Intern Med; 1985 Jul; 145(7):1200-3. PubMed ID: 4015266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a postsecretory reabsorptive site for uric acid in man.
    Diamond HS; Paolino JS
    J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid saturation in calcium nephrolithiasis.
    Coe FL; Strauss AL; Tembe V; Le Dun S
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urate nephrolithiasis. Cause of consequence?].
    Mertz DP
    Fortschr Med; 1976 Jul; 94(20-21):1160-4. PubMed ID: 955552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of urate renal handling in humans: pyrazinamide test vs combined pyrazinamide and probenecid administration.
    Colussi G; Rombolà G; De Ferrari ME; Rolando P; Surian M; Malberti F; Minetti L
    Nephrol Dial Transplant; 1987; 2(1):10-6. PubMed ID: 3110689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal urate transport in erythrocytes of patients with idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria.
    Gambaro G; Vincenti M; Marchini F; D'Angelo A; Baggio B
    Clin Sci (Lond); 1993 Jul; 85(1):41-4. PubMed ID: 8149692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1982 Mar; 127(3):589-92. PubMed ID: 7062444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of uric acid in normal subjects by means of the pyrazinamide and probenecid tests.
    Garcia Puig J; Mateos Antón F; Muñoz Sanz A; Gaspar G; Lesmes A; Ramos T; Ortiz Vázquez J
    Nephron; 1983; 35(3):183-6. PubMed ID: 6633758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricosuria in the Fanconi syndrome.
    Meisel AD; Diamond HS
    Am J Med Sci; 1977; 273(1):109-15. PubMed ID: 848505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypouricemia due to increased tubular secretion of urate in children with Amanita phalloides poisoning.
    Zawadzki J; Jankowska I; Moszczyńska A; Januszewicz P
    Nephron; 1993; 65(3):375-80. PubMed ID: 8289987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uric acid and arterial hypertension. II. Evaluation of uric acid transport in the nephrons in primary arterial hypertension].
    Tykarski A
    Pol Arch Med Wewn; 1991 Sep; 86(3):167-76. PubMed ID: 1808601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid nephrolithiasis.
    Halabe A; Sperling O
    Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urate metabolism and renal calcium stone disease.
    Fellström B
    Scand J Urol Nephrol Suppl; 1981; 62():1-59. PubMed ID: 6960474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nifedipine on tubular handling of uric acid in transplanted kidney on cyclosporine A treatment.
    Zawadzki J; Grenda R; Januszewicz P
    Nephron; 1995; 70(1):77-82. PubMed ID: 7617121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid elimination in the urine. Pathophysiological implications.
    Marangella M
    Contrib Nephrol; 2005; 147():132-148. PubMed ID: 15604613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.